vendredi 24 juin 2016
CRISPR gene editing heads to human trial as cancer treatment
Approval in the U.S. of a human trial using the gene-editing technique called CRISPR to target certain cancers could open the door to dozens of trials using the promising new technology.
Related Posts:
Many prescription opioid addicts engage in 'doctor shopping' before overdose deaths- A Really Good Day: How microdosing LSD helped Ayelet Waldman pull back from the depths of depression
- A Really Good Day: How microdosing LSD helped Ayelet Waldman pull back from the depths of depression
- New operating rooms will barely reduce surgery wait times, says iconic B.C. doctor
- Many prescription opioid addicts engage in 'doctor shopping' before overdose deaths
Articles
0 comments:
Enregistrer un commentaire